DanCann Pharma Feed

	Est. tid*
2025-10-27	18:00	Kvartalsrapport 2025-Q3
2025-08-25	18:00	Kvartalsrapport 2025-Q2
2025-05-23	-	Kvartalsrapport 2025-Q1
2025-04-24	-	Årsstämma
2025-04-12	-	X-dag ordinarie utdelning DANCAN 0.00 DKK
2025-02-24	-	Split DANCAN 1000:1
2025-02-17	-	Bokslutskommuniké 2024
2025-01-21	-	Extra Bolagsstämma 2025
2024-12-10	-	Extra Bolagsstämma 2024
2024-11-22	-	Kvartalsrapport 2024-Q3
2024-08-14	-	Kvartalsrapport 2024-Q2
2024-06-01	-	Kvartalsrapport 2024-Q1
2024-05-30	-	Årsstämma
2024-04-22	-	X-dag ordinarie utdelning DANCAN 0.00 DKK
2024-02-28	-	Bokslutskommuniké 2023
2023-11-30	-	Kvartalsrapport 2023-Q3
2023-08-31	-	Kvartalsrapport 2023-Q2
2023-05-31	-	Kvartalsrapport 2023-Q1
2023-04-19	-	X-dag ordinarie utdelning DANCAN 0.00 DKK
2023-04-18	-	Årsstämma
2023-02-28	-	Bokslutskommuniké 2022
2022-11-04	-	Kvartalsrapport 2022-Q3
2022-09-20	-	Extra Bolagsstämma 2022
2022-08-31	-	Kvartalsrapport 2022-Q2
2022-05-18	-	Kvartalsrapport 2022-Q1
2022-04-27	-	Årsstämma
2022-04-08	-	X-dag ordinarie utdelning DANCAN 0.00 DKK
2022-02-25	-	Bokslutskommuniké 2021
2021-11-26	-	Kvartalsrapport 2021-Q3
2021-08-27	-	Kvartalsrapport 2021-Q2
2021-07-23	-	Extra Bolagsstämma 2021
2021-05-28	-	Kvartalsrapport 2021-Q1
2021-04-29	-	X-dag ordinarie utdelning DANCAN 0.00 DKK
2021-04-28	-	Årsstämma
2021-02-26	-	Bokslutskommuniké 2020

Land	Danmark
Lista	Spotlight DK
Sektor	Hälsovård
Industri	Läkemedel & Handel

2025-07-09 22:15:00 DanCann Pharma A/S shares supplementary details of the obtained bridge loan 0,95 DKK | -20,17% | 0,16 MDKK

2025-07-09 11:00:00 DanCann Pharma A/S signs a conditional sales agreement for the sale of manufacturing site (BP1), secures bridge financing, and launches new strategy, Maturity2028 1,19 DKK | +7,21% | 0,47 MDKK

2025-05-23 17:05:00 DanCann Pharma A/S: Delivers Q1-2025 Highlights - Expands Prescription (Rx) Portfolio, Eyes Consumer Health Market Entry (OTC) 1,64 DKK | 0,00% | 0,12 MDKK

2025-05-23 17:05:00 DanCann Pharma A/S: Præsenterer højdepunkter fra 1. kvartal 2025 - Udvider receptportefølje (Rx) og forbereder indtræden på markedet for håndkøbsprodukter (OTC) 1,64 DKK | 0,00% | 0,12 MDKK

2025-05-19 08:30:00 DanCann Pharma A/S: Modtager Lægemiddelstyrelsens godkendelse af Bedrolite® og Bedrobinol® under den danske forsøgsordning 1,45 DKK | +12,40% | 0,15 MDKK

2025-05-19 08:30:00 DanCann Pharma A/S: Receives Regulatory Approval for Bedrolite® and Bedrobinol® from the Danish Medicines Agency under the Danish Pilot Programme 1,45 DKK | +12,40% | 0,15 MDKK

2025-04-25 08:45:00 DanCann Pharma A/S: Adoption of Permanent Medicinal Cannabis Legislation in Denmark Completed 1,48 DKK | -3,90% | 0,02 MDKK

2025-04-24 11:30:00 DanCann Pharma A/S: Updated Financial Calendar for the Remainder of 2025 1,54 DKK | +9,22% | 0,01 MDKK

2025-04-24 11:15:00 DanCann Pharma: DANCANN PHARMA A/S: MINUTES OF ANNUAL GENERAL MEETING 1,54 DKK | +9,22% | 0,01 MDKK

2025-04-04 17:50:00 DanCann Pharma A/S: Notice of Annual General Meeting in DanCann Pharma A/S

2025-04-04 17:45:00 DanCann Pharma A/S Releases 2024 Annual Report Highlighting Growth and Operational Efficiency

2025-03-27 20:00:00 DanCann Pharma A/S: Postponement of release of annual report 2024 and AGM 2025 1,71 DKK | +0,29% | 0,01 MDKK

2025-03-13 13:00:00 DanCann Pharma A/S forges cutting edge alliance with Tetra Pharm Technologies ApS 1,60 DKK | 0,00% | 0,07 MDKK

2025-02-18 14:15:00 DanCann Pharma A/S: Completion of reverse share split and redemption of shares 2,00 DKK | 0,00% | 0,02 MDKK

2025-02-17 08:15:00 DanCann Pharma A/S Publishes Its Consultation Response ("Høringssvar") to the New Legislation on Medicinal Cannabis in Denmark 2,00 DKK | +11,11% | 0,03 MDKK

2025-02-17 08:15:00 DanCann Pharma A/S Offentliggør Selskabets Høringssvar til den Nye Lovgivning om Medicinsk Cannabis i Danmark 2,00 DKK | +11,11% | 0,03 MDKK

2025-02-17 08:00:00 DanCann Pharma A/S: Releases Q4-2024 report - Revenue (NET) up by 27.8% YoY and EBITDA up by 63.8% YoY 2,00 DKK | +11,11% | 0,03 MDKK

2025-01-21 17:45:00 DanCann Pharma A/S: Notice of redemption of shares in connection with reverse share split in the ratio 1,000:1 2,20 DKK | 0,00% | 0,02 MDKK

2025-01-21 17:30:00 DanCann Pharma A/S: Minutes of Extraordinary General Meeting 2,20 DKK | 0,00% | 0,02 MDKK

2025-01-06 08:30:00 DanCann Pharma A/S: Notice of proposal to Consolidate Shares in DanCann Pharma A/S 2,40 DKK | -7,69% | 0,12 MDKK

2025-01-06 08:00:00 DanCann Pharma: NOTICE OF EXTRAORDINARY GENERAL MEETING IN DANCANN PHARMA A/S 2,40 DKK | -7,69% | 0,12 MDKK

2024-12-10 14:15:00 DanCann Pharma A/S: DanCann Pharma Announces Outcome of Directed Issues to Board and Management 3,20 DKK | +14,29% | 0,35 MDKK

2024-12-10 14:00:00 DanCann Pharma A/S: Minutes of Extraordinary General Meeting 3,20 DKK | +14,29% | 0,35 MDKK

2024-11-29 08:00:00 DanCann Pharma A/S: Agreement Reached on Permanent Medicinal Cannabis Scheme in Denmark 9,60 DKK | +11,63% | 1,53 MDKK

2024-11-25 10:20:00 DanCann Pharma A/S Recommends Experienced Politician and Senior Government Official to Join the Board of Directors 10,00 DKK | -13,79% | 5,25 MDKK

2024-11-25 10:15:00 DanCann Pharma: NOTICE OF EXTRAORDINARY GENERAL MEETING IN DANCANN PHARMA A/S 10,00 DKK | -13,79% | 5,25 MDKK

2024-11-25 08:00:00 DanCann Pharma A/S: The Board of Directors has resolved on directed share issues of DKK 4.5 million and proposal of directed share issues of DKK 0.4 million 10,00 DKK | -13,79% | 5,25 MDKK

2024-11-22 17:30:00 DanCann Pharma A/S Publishes Q3-2024 Report: Steady Growth in Medicinal Cannabis Prescriptions Signals Promising Future for Patients

2024-11-19 09:30:00 DanCann Pharma A/S: The Danish Government Proposes Permanent Scheme for Prescription-Based Medicinal Cannabis for Danish Patients 5,00 DKK | +47,06% | 0,71 MDKK

2024-11-05 17:30:00 DanCann Pharma A/S: Capital reduction in DanCann Pharma A/S is completed 3,60 DKK | -5,26% | 0,05 MDKK

2024-10-07 12:30:00 DanCann Pharma: Minutes of extraordinary general meeting 4,80 DKK | -4,00% | 0,07 MDKK

2024-09-24 16:00:00 DanCann Pharma A/S: Calls for an Extraordinary General Meeting regarding New Authorizations and Reduction of Share Capital in Preparation for Reverse Stock Split 5,20 DKK | -10,34% | 0,19 MDKK

2024-09-20 18:00:00 DanCann Pharma: NOTICE OF EXTRAORDINARY GENERAL MEETING IN DANCANN PHARMA A/S

2024-09-18 12:00:00 DanCann Pharma A/S: Number of Reported Suspected Adverse Reactions Drops by Two-Thirds in 2023 Despite 72% Growth in the Medicinal Cannabis Pilot Programme 7,40 DKK | +2,78% | 0,05 MDKK

2024-08-14 08:15:00 DanCann Pharma A/S: Quarterly CEO Reflection 7,80 DKK | +44,44% | 1,20 MDKK

2024-08-14 08:00:00 DanCann Pharma A/S Publishes Q2-2024 Report: Record Revenue and First-Ever Positive EBITDA 7,80 DKK | +44,44% | 1,20 MDKK

2024-07-03 08:00:00 DanCann Pharma A/S announces last day for trading in temporary shares 40,40 DKK | +1,51% | 0,11 MDKK

2024-06-27 18:45:00 DanCann Pharma A/S announces outcome of the Rights Issue 41,00 DKK | +7,89% | 0,06 MDKK

2024-06-19 12:00:00 DanCann Pharma A/S: Last day of subscription of shares in the ongoing Rights Issue is 20 June 2024 on Nordnet Bank and Avanza Bank 46,20 DKK | +13,24% | 0,11 MDKK

2024-06-18 13:00:00 DanCann Pharma A/S: Solid growth in the Rx portfolio 40,80 DKK | +23,64% | 0,06 MDKK

2024-06-14 09:00:00 DanCann Pharma A/S: Germany trends - prescriptions for medicinal cannabis positively influenced by new legalization 36,60 DKK | -14,88% | 0,10 MDKK

2024-06-12 09:00:00 DanCann Pharma A/S: Submits applications for FLS03 and FLS04 to expand portfolio 51,00 DKK | 0,00% | 0,14 MDKK

2024-06-11 08:00:00 DanCann Pharma A/S: The subscription period of DanCann Pharma's Rights Issue begins today 51,00 DKK | -26,93% | 0,38 MDKK

2024-06-01 19:30:00 DanCann Pharma A/S: Publishes Q1-2024 Report

2024-05-30 12:15:00 DanCann Pharma A/S: Minutes OF ANNUAL GENERAL MEETING 13,86 DKK | +18,01% | 0,06 MDKK

2024-05-24 10:15:00 DanCann Pharma A/S: The Board of Directors has resolved on a partially (48.88 percent) secured Rights Issue of approximately DKK 18.33 million and publishes memorandum 16,42 DKK | -10,06% | 0,05 MDKK

2024-05-16 20:30:00 DanCann Pharma A/S: Capital reduction completed 18,09 DKK | -7,14% | 0,05 MDKK

2024-05-15 22:15:00 DanCann Pharma: NOTICE OF ANNUAL GENERAL MEETING 2024 IN DANCANN PHARMA A/S 19,49 DKK | -12,50% | 0,26 MDKK

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

DanCann Pharma

Kalender

Beskrivning

DanCann Pharma

Kalender

Beskrivning

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden